NIH/Biosite Licensing Agreement Proposed For Atherosclerosis Gene Markers
This article was originally published in The Gray Sheet
Executive Summary
Biosite is contemplating exclusively licensing genetic markers from the National Institutes of Health for the early diagnosis of coronary artery disease